Tsuyoshi Ichikawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tsuyoshi Ichikawa has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Masato Katagiri
School of Allied Health Sciences Kitasato University Sagamihara Kanagawa Japan
8 shared publicationsMasanori Yokoba
School of Allied Health Sciences Kitasato University Sagamihara Kanagawa Japan
6 shared publicationsAkiko Kawakami
Rehabilitation Centre Tokai University Oiso Hospital Oiso Kanagawa Japan
4 shared publications- Masanori Yokoba
School of Allied Health Sciences, Kitasato University, Kanagawa, Japan
4 shared publications Minoru Toyokura
Department of Rehabilitation Medicine Tokai University Oiso Hospital Oiso Kanagawa Japan
4 shared publicationsSaki Yamaguchi
Department of Rehabilitation Services Tokai University Hachioji Hospital Tokyo Japan
4 shared publications
Latest Publications
- 31 October 2023
- Published by Elsevier in Respiratory Medicine
- Vol. 219, 107438
Sniff and reverse-sniff nasal respiratory pressures after exacerbation of chronic obstructive pulmonary disease: A single-center prospective study
- 31 October 2023
- Published by Elsevier in Respiratory Medicine
- Vol. 219, 107438
Sniff and reverse-sniff nasal respiratory pressures after exacerbation of chronic obstructive pulmonary disease: A single-center prospective study
- Open Access
- 23 May 2023
- Published by VM Media Group sp. z o.o in Folia Morphologica
- Vol. 82 (2) , 300-306
Congenital venous anomalies associated with retrocaval ureter: evaluation using computed tomography
Background: Retrocaval ureter is a rare congenital anomaly resulting from anomalous development of inferior vena cava (IVC) and not from anomalous of the ureter. The anomaly always occurs on the right side due to regression of right supracardinal vein and persistence of right posterior cardinal vein. Retrocaval ureter tends to be associated with various vena cava anomalies because of the embryogenesis. We aimed to identify the prevalence of associated congenital venous anomalies (CVA) resulting from cardinal vein development in adults with retrocaval ureter using computed tomography (CT) images. Materials and methods: The study included 22 adults with retrocaval ureter. We evaluated CT findings and determined the incidence of associated CVA using thin slice data sets from CT scanner with 64 or more detectors. We compared the prevalence of CVA in the retrocaval ureter group (mean age: 57±19 years) and in the control group of 6189 adults with normal ureter (mean age: 66±14 years). Results: In the retrocaval ureter group, 4 adults (18.2 %) had CVA including double IVC, right double IVC, preisthmic IVC with horseshoe kidney, and preaortic iliac confluence. One of 2 adults with preaortic iliac confluence had right double right IVC. In the control group, 49 adults (0.79%) had CVA including 37 double IVCe, 11 left IVCe, and 1 IVC interruption azygos continuation. Fifteen horseshow kidneys were found. The prevalence of associated CVA in the retrocaval ureter group was higher than that in the control group (pConclusions: Retrocaval ureter is frequently associated with CVA. Various CVA with retrocaval ureter could happen because of abnormal development of not only the right posterior or supra cardinal vein but also other cardinal veins. Background: Retrocaval ureter is a rare congenital anomaly resulting from anomalous development of inferior vena cava (IVC) and not from anomalous of the ureter. The anomaly always occurs on the right side due to regression of right supracardinal vein and persistence of right posterior cardinal vein. Retrocaval ureter tends to be associated with various vena cava anomalies because of the embryogenesis. We aimed to identify the prevalence of associated congenital venous anomalies (CVA) resulting from cardinal vein development in adults with retrocaval ureter using computed tomography (CT) images. Materials and methods: The study included 22 adults with retrocaval ureter. We evaluated CT findings and determined the incidence of associated CVA using thin slice data sets from CT scanner with 64 or more detectors. We compared the prevalence of CVA in the retrocaval ureter group (mean age: 57±19 years) and in the control group of 6189 adults with normal ureter (mean age: 66±14 years). Results: In the retrocaval ureter group, 4 adults (18.2 %) had CVA including double IVC, right double IVC, preisthmic IVC with horseshoe kidney, and preaortic iliac confluence. One of 2 adults with preaortic iliac confluence had right double right IVC. In the control group, 49 adults (0.79%) had CVA including 37 double IVCe, 11 left IVCe, and 1 IVC interruption azygos continuation. Fifteen horseshow kidneys were found. The prevalence of associated CVA in the retrocaval ureter group was higher than that in the control group (pConclusions: Retrocaval ureter is frequently associated with CVA. Various CVA with retrocaval ureter could happen because of abnormal development of not only the right posterior or supra cardinal vein but also other cardinal veins.
- 23 May 2023
- Published by VM Media Group sp. z o.o in Folia Morphologica
- Vol. 82 (2) , 300-306
Open AccessCongenital venous anomalies associated with retrocaval ureter: evaluation using computed tomography
Background: Retrocaval ureter is a rare congenital anomaly resulting from anomalous development of inferior vena cava (IVC) and not from anomalous of the ureter. The anomaly always occurs on the right side due to regression of right supracardinal vein and persistence of right posterior cardinal vein. Retrocaval ureter tends to be associated with various vena cava anomalies because of the embryogenesis. We aimed to identify the prevalence of associated congenital venous anomalies (CVA) resulting from cardinal vein development in adults with retrocaval ureter using computed tomography (CT) images. Materials and methods: The study included 22 adults with retrocaval ureter. We evaluated CT findings and determined the incidence of associated CVA using thin slice data sets from CT scanner with 64 or more detectors. We compared the prevalence of CVA in the retrocaval ureter group (mean age: 57±19 years) and in the control group of 6189 adults with normal ureter (mean age: 66±14 years). Results: In the retrocaval ureter group, 4 adults (18.2 %) had CVA including double IVC, right double IVC, preisthmic IVC with horseshoe kidney, and preaortic iliac confluence. One of 2 adults with preaortic iliac confluence had right double right IVC. In the control group, 49 adults (0.79%) had CVA including 37 double IVCe, 11 left IVCe, and 1 IVC interruption azygos continuation. Fifteen horseshow kidneys were found. The prevalence of associated CVA in the retrocaval ureter group was higher than that in the control group (pConclusions: Retrocaval ureter is frequently associated with CVA. Various CVA with retrocaval ureter could happen because of abnormal development of not only the right posterior or supra cardinal vein but also other cardinal veins. Background: Retrocaval ureter is a rare congenital anomaly resulting from anomalous development of inferior vena cava (IVC) and not from anomalous of the ureter. The anomaly always occurs on the right side due to regression of right supracardinal vein and persistence of right posterior cardinal vein. Retrocaval ureter tends to be associated with various vena cava anomalies because of the embryogenesis. We aimed to identify the prevalence of associated congenital venous anomalies (CVA) resulting from cardinal vein development in adults with retrocaval ureter using computed tomography (CT) images. Materials and methods: The study included 22 adults with retrocaval ureter. We evaluated CT findings and determined the incidence of associated CVA using thin slice data sets from CT scanner with 64 or more detectors. We compared the prevalence of CVA in the retrocaval ureter group (mean age: 57±19 years) and in the control group of 6189 adults with normal ureter (mean age: 66±14 years). Results: In the retrocaval ureter group, 4 adults (18.2 %) had CVA including double IVC, right double IVC, preisthmic IVC with horseshoe kidney, and preaortic iliac confluence. One of 2 adults with preaortic iliac confluence had right double right IVC. In the control group, 49 adults (0.79%) had CVA including 37 double IVCe, 11 left IVCe, and 1 IVC interruption azygos continuation. Fifteen horseshow kidneys were found. The prevalence of associated CVA in the retrocaval ureter group was higher than that in the control group (pConclusions: Retrocaval ureter is frequently associated with CVA. Various CVA with retrocaval ureter could happen because of abnormal development of not only the right posterior or supra cardinal vein but also other cardinal veins.
- 19 July 2022
- Published by Wiley in European Journal of Cancer Care
- Vol. 31 (6) , e13663
Recovery of respiratory muscle strength, physical function, and dyspnoea after lobectomy in lung cancer patients undergoing pulmonary rehabilitation: A retrospective study
To characterise changes in respiratory muscle strength, physical function, and dyspnoea in patients who underwent pre- and post-operative exercise intervention following lobectomy for non-small-cell lung cancer (NSCLC). This retrospective study included NSCLC patients who underwent lobectomy via video-assisted thoracoscopic surgery (VATS) or posterolateral thoracotomy (PLT) and pre- and post-operative exercise intervention consisting of breathing, flexibility, resistance, aerobic exercises, coughing/huffing techniques, and early mobilisation. Maximum mouth inspiratory (Pimax) and expiratory pressures (Pemax), 6-min walk distance (6MWD), quadriceps force (QF), and modified Medical Research Council (mMRC) dyspnoea scale were evaluated preoperatively, at hospital discharge, and post-lobectomy 1 and 3 months. Data from 41 patients were analysed. At hospital discharge, the Pimax, Pemax, 6MWD, and mMRC dyspnoea scores were lower than pre-operatively; QF remained unchanged; Pimax and 6MWD recovered to pre-operative values at post-lobectomy 1 month; and Pemax and mMRC dyspnoea scores recovered at 3 months. During sub-analysis, Pimax and mMRC dyspnoea scores in the VATS (n = 24) and PLT groups (n = 17) recovered to pre-operative values at post-lobectomy 1 and 3 months. After lobectomy, respiratory muscle strength, physical function, and dyspnoea in patients who underwent exercise intervention returned to pre-operative values at post-lobectomy 3 months.
- 19 July 2022
- Published by Wiley in European Journal of Cancer Care
- Vol. 31 (6) , e13663
Recovery of respiratory muscle strength, physical function, and dyspnoea after lobectomy in lung cancer patients undergoing pulmonary rehabilitation: A retrospective study
To characterise changes in respiratory muscle strength, physical function, and dyspnoea in patients who underwent pre- and post-operative exercise intervention following lobectomy for non-small-cell lung cancer (NSCLC). This retrospective study included NSCLC patients who underwent lobectomy via video-assisted thoracoscopic surgery (VATS) or posterolateral thoracotomy (PLT) and pre- and post-operative exercise intervention consisting of breathing, flexibility, resistance, aerobic exercises, coughing/huffing techniques, and early mobilisation. Maximum mouth inspiratory (Pimax) and expiratory pressures (Pemax), 6-min walk distance (6MWD), quadriceps force (QF), and modified Medical Research Council (mMRC) dyspnoea scale were evaluated preoperatively, at hospital discharge, and post-lobectomy 1 and 3 months. Data from 41 patients were analysed. At hospital discharge, the Pimax, Pemax, 6MWD, and mMRC dyspnoea scores were lower than pre-operatively; QF remained unchanged; Pimax and 6MWD recovered to pre-operative values at post-lobectomy 1 month; and Pemax and mMRC dyspnoea scores recovered at 3 months. During sub-analysis, Pimax and mMRC dyspnoea scores in the VATS (n = 24) and PLT groups (n = 17) recovered to pre-operative values at post-lobectomy 1 and 3 months. After lobectomy, respiratory muscle strength, physical function, and dyspnoea in patients who underwent exercise intervention returned to pre-operative values at post-lobectomy 3 months.
- Open Access
- 15 March 2021
- Published by Springer Nature in Research Square
Recovery of Respiratory Muscle, Physical Functions, and Dyspnea After Lobectomy for Lung Cancer
Purpose: To characterize respiratory muscle strength, physical functions, and dyspnea in patients receiving pulmonary rehabilitation following lobectomy for non-small cell lung cancer.Methods: This retrospective study included non-small cell lung cancer patients who underwent lobectomy via video-assisted thoracoscopic surgery or posterolateral thoracotomy and pulmonary rehabilitation between September 2013 and March 2018. Maximum mouth inspiratory and expiratory pressures, 6-minute walking distance, quadriceps force, and modified Medical Research Council dyspnea scale score were evaluated before surgery, at discharge, and at post-lobectomy months 1 and 3.Results: Data from 41 eligible patients were analyzed. At discharge, maximum mouth inspiratory and expiratory pressures, 6-minute walking distance, and modified Medical Research Council dyspnea scale score were lower than pre-operative values, but quadriceps force was unchanged. The maximum mouth inspiratory pressure and 6-minute walking distance returned to pre-operative values at post-lobectomy month 1, and maximum expiratory pressure and modified Medical Research Council dyspnea scale score improved at month 3. During sub-analysis, maximum mouth inspiratory pressure and modified Medical Research Council dyspnea scale score after video-assisted thoracoscopic surgery (n = 24) improved to pre-operative levels at post-lobectomy month 1, whereas patients in the posterolateral thoracotomy group (n = 17), it improved at 3 months.Conclusions: After lobectomy for non-small cell lung cancer, patients undergoing pulmonary rehabilitation had their respiratory muscle strength, physical functions, and dyspnea improve to pre-operative levels at post-lobectomy month 3. Moreover, video-assisted thoracoscopic surgery may be more beneficial than posterolateral thoracotomy in the early post-operative recovery of inspiratory muscle strength and dyspnea.
- 15 March 2021
- Published by Springer Nature in Research Square
Open AccessRecovery of Respiratory Muscle, Physical Functions, and Dyspnea After Lobectomy for Lung Cancer
Purpose: To characterize respiratory muscle strength, physical functions, and dyspnea in patients receiving pulmonary rehabilitation following lobectomy for non-small cell lung cancer.Methods: This retrospective study included non-small cell lung cancer patients who underwent lobectomy via video-assisted thoracoscopic surgery or posterolateral thoracotomy and pulmonary rehabilitation between September 2013 and March 2018. Maximum mouth inspiratory and expiratory pressures, 6-minute walking distance, quadriceps force, and modified Medical Research Council dyspnea scale score were evaluated before surgery, at discharge, and at post-lobectomy months 1 and 3.Results: Data from 41 eligible patients were analyzed. At discharge, maximum mouth inspiratory and expiratory pressures, 6-minute walking distance, and modified Medical Research Council dyspnea scale score were lower than pre-operative values, but quadriceps force was unchanged. The maximum mouth inspiratory pressure and 6-minute walking distance returned to pre-operative values at post-lobectomy month 1, and maximum expiratory pressure and modified Medical Research Council dyspnea scale score improved at month 3. During sub-analysis, maximum mouth inspiratory pressure and modified Medical Research Council dyspnea scale score after video-assisted thoracoscopic surgery (n = 24) improved to pre-operative levels at post-lobectomy month 1, whereas patients in the posterolateral thoracotomy group (n = 17), it improved at 3 months.Conclusions: After lobectomy for non-small cell lung cancer, patients undergoing pulmonary rehabilitation had their respiratory muscle strength, physical functions, and dyspnea improve to pre-operative levels at post-lobectomy month 3. Moreover, video-assisted thoracoscopic surgery may be more beneficial than posterolateral thoracotomy in the early post-operative recovery of inspiratory muscle strength and dyspnea.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Sniff nasal inspiratory pressure as a predictor of 1-year mortality after exacerbation of COPD
Introduction: The maximal sniff nasal inspiratory pressure (SNIP) is widely used as a simple assessment of inspiratory muscle strength. Both SNIP and the BODE index have been reported to be able to predict mortality in stable COPD (Moore AJ, et al. 2010 and Celli BR, et al. 2004). Aims: This study aimed to compare SNIP to the BODE index as predictors of 1-year mortality in patients with COPD after an exacerbation. Methods: A prospective mortality analysis of 48 patients admitted for exacerbation of COPD [39 male, age median 78 (IQR 72-82) years, length of stay 19 (12-35) days] was performed (Ethics 15R149). All patients underwent pulmonary rehabilitation during hospitalization. At discharge, SNIP and the BODE index were measured. Mortality was followed up for 1-year after discharge. Predictive ability for mortality was tested using multivariate Cox proportional hazard (PH) model adjusted for age and gender, and discriminatory power by the area under the receiver operating characteristic curve (AUC). Results: 7 patients (15%) died during the study period. At discharge, SNIP and the BODE index were 47 (35-60) cmH2O and 6 (4-7) [FEV1 44 (34-55) % predicted, BMI 21 (18-24) kg/m2, 6-min walk distance 220 (164-279) m, mMRC dyspnea scale 3 (2-3)], respectively. In a Cox PH model including SNIP and the BODE index, only SNIP was a significant predictor of mortality [the hazard ratio: 0.935, 95% confidence interval (CI) 0.882-0.992, p=0.026]. The AUC of SNIP was 0.787 (95% CI 0.588-0.987, p=0.016), and a cut-off value was 35 cmH2O (sensitivity 71%, specificity 83%). Conclusions: We found that SNIP may be more beneficial than the BODE index as a predictor of 1-year mortality after exacerbation of COPD.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Sniff nasal inspiratory pressure as a predictor of 1-year mortality after exacerbation of COPD
Introduction: The maximal sniff nasal inspiratory pressure (SNIP) is widely used as a simple assessment of inspiratory muscle strength. Both SNIP and the BODE index have been reported to be able to predict mortality in stable COPD (Moore AJ, et al. 2010 and Celli BR, et al. 2004). Aims: This study aimed to compare SNIP to the BODE index as predictors of 1-year mortality in patients with COPD after an exacerbation. Methods: A prospective mortality analysis of 48 patients admitted for exacerbation of COPD [39 male, age median 78 (IQR 72-82) years, length of stay 19 (12-35) days] was performed (Ethics 15R149). All patients underwent pulmonary rehabilitation during hospitalization. At discharge, SNIP and the BODE index were measured. Mortality was followed up for 1-year after discharge. Predictive ability for mortality was tested using multivariate Cox proportional hazard (PH) model adjusted for age and gender, and discriminatory power by the area under the receiver operating characteristic curve (AUC). Results: 7 patients (15%) died during the study period. At discharge, SNIP and the BODE index were 47 (35-60) cmH2O and 6 (4-7) [FEV1 44 (34-55) % predicted, BMI 21 (18-24) kg/m2, 6-min walk distance 220 (164-279) m, mMRC dyspnea scale 3 (2-3)], respectively. In a Cox PH model including SNIP and the BODE index, only SNIP was a significant predictor of mortality [the hazard ratio: 0.935, 95% confidence interval (CI) 0.882-0.992, p=0.026]. The AUC of SNIP was 0.787 (95% CI 0.588-0.987, p=0.016), and a cut-off value was 35 cmH2O (sensitivity 71%, specificity 83%). Conclusions: We found that SNIP may be more beneficial than the BODE index as a predictor of 1-year mortality after exacerbation of COPD.
- 28 September 2019
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 54 (suppl 63) , OA3791
Respiratory muscle strength and dyspnea after lobectomy via video-assisted thoracoscopic surgery or thoracotomy for lung cancer
Introduction: Video-assisted thoracoscopic surgery (VATS) lobectomy has been reported to decrease incidence of postoperative complications and chest pain compared to thoracotomy for lung cancer. Aims: This study aimed to reveal the postoperative recovery of respiratory muscle strength and dyspnea after lobectomy via VATS or posterolateral thoracotomy (PLT) for patients with non-small cell lung cancer (NSCLC) undergoing pulmonary rehabilitation (PR). Methods: We analyzed the data of 43 patients with NSCLC who underwent lobectomy via VATS (n=25) or PLT (n=18). They performed PR from 1 week before to 3 months after lobectomy. FVC, FEV1, 6-minute walk distance (6MD), maximal inspiratory (PImax) and expiratory (PEmax) mouth pressures, and mMRC dyspnea grade were evaluated preoperatively, and at 1 and 3 months after lobectomy (1M and 3M). (Ethics # 17R389) Results: There were no differences between VATS and PLT in the preoperative values of each parameter. As for the postoperative recovery of FVC, FEV1, PEmax, and 6MD, there were no differences between VATS and PLT. In VATS, PImax and mMRC at 1M (PImax 103±38% predicted; mMRC 1 [IQR 0-1]) and 3M (PImax 107±37% predicted; mMRC 0 [IQR 0-1]) did not become worse than preoperative values (PImax 99±35% predicted; mMRC 0 [0-1]). In PLT, PImax and mMRC at 1M deteriorated compared to preoperative values (PImax 90±23% vs 102±29% predicted and mMRC 1 [1-2] vs 0 [0-1], p<0.05), but improved at 3M (PImax 115±37% predicted; mMRC 0 [0-1]). Conclusions: We found that VATS lobectomy may be more beneficial than PLT in the early postoperative recovery of inspiratory muscle strength and dyspnea for patients with NSCLC undergoing PR.
- 28 September 2019
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 54 (suppl 63) , OA3791
Respiratory muscle strength and dyspnea after lobectomy via video-assisted thoracoscopic surgery or thoracotomy for lung cancer
Introduction: Video-assisted thoracoscopic surgery (VATS) lobectomy has been reported to decrease incidence of postoperative complications and chest pain compared to thoracotomy for lung cancer. Aims: This study aimed to reveal the postoperative recovery of respiratory muscle strength and dyspnea after lobectomy via VATS or posterolateral thoracotomy (PLT) for patients with non-small cell lung cancer (NSCLC) undergoing pulmonary rehabilitation (PR). Methods: We analyzed the data of 43 patients with NSCLC who underwent lobectomy via VATS (n=25) or PLT (n=18). They performed PR from 1 week before to 3 months after lobectomy. FVC, FEV1, 6-minute walk distance (6MD), maximal inspiratory (PImax) and expiratory (PEmax) mouth pressures, and mMRC dyspnea grade were evaluated preoperatively, and at 1 and 3 months after lobectomy (1M and 3M). (Ethics # 17R389) Results: There were no differences between VATS and PLT in the preoperative values of each parameter. As for the postoperative recovery of FVC, FEV1, PEmax, and 6MD, there were no differences between VATS and PLT. In VATS, PImax and mMRC at 1M (PImax 103±38% predicted; mMRC 1 [IQR 0-1]) and 3M (PImax 107±37% predicted; mMRC 0 [IQR 0-1]) did not become worse than preoperative values (PImax 99±35% predicted; mMRC 0 [0-1]). In PLT, PImax and mMRC at 1M deteriorated compared to preoperative values (PImax 90±23% vs 102±29% predicted and mMRC 1 [1-2] vs 0 [0-1], p<0.05), but improved at 3M (PImax 115±37% predicted; mMRC 0 [0-1]). Conclusions: We found that VATS lobectomy may be more beneficial than PLT in the early postoperative recovery of inspiratory muscle strength and dyspnea for patients with NSCLC undergoing PR.
- 1 December 2018
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 10 (12) , 6891-6902
Postoperative pulmonary function changes according to the resected lobe: a 1-year follow-up study of lobectomized patients
Background: Pulmonary function and patient complaints appear to improve up to 12 months after lobectomy but long-term prospective studies based on clinical data are scarce. Improvement in pulmonary function may depend on the area and extent of the resection and the time from the operation. This prospective study aimed to determine pulmonary function changes according to the resected lobe. Methods: This prospective study included 59 patients requiring single lobectomy. Total volume and low-attenuation volume (LAV) for each lobe and the entire lungs were calculated based on helical computed tomography images. Vital capacity (VC), forced expiratory volume in one second (FEV1), percent FEV1 (%FEV1), percent lung diffusion capacity for carbon monoxide (%DLco), %DLco divided by the alveolar volume (%DLco/VA), modified Medical Research Council (mMRC) grades, and COPD Assessment Test (CAT) scores were compared at 3, 6, and 12 months after surgery. Results: VC was higher at 12 months than at 3 months after right upper lobectomy (RUL) or right lower lobectomy (RLL). FEV1 and %FEV1 were higher at 12 months than at 6 months after left lower lobectomy (LLL). %DLco was higher at 12 months than at 3 months after RUL or left upper lobectomy (LUL). DLco/VA, mMRC grades, and CAT scores did not change significantly in the period from 3 to 12 months after any lobectomy procedure. Compared to the predicted postoperative values, the observed values of VC for RUL, RLL, and LUL; FEV1 for RLL; %FEV1 for RLL and LUL; %DLco for LUL; and %DLco/VA for all lobectomy procedures were higher at 12 months. Conclusions: Improvements in pulmonary function and symptoms varied according to the resected lobe. Some of the observed pulmonary function values were higher than the predicted postoperative values. Pulmonary function changes may be related to the location, volume, and extent of emphysematous changes.
- 1 December 2018
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 10 (12) , 6891-6902
Postoperative pulmonary function changes according to the resected lobe: a 1-year follow-up study of lobectomized patients
Background: Pulmonary function and patient complaints appear to improve up to 12 months after lobectomy but long-term prospective studies based on clinical data are scarce. Improvement in pulmonary function may depend on the area and extent of the resection and the time from the operation. This prospective study aimed to determine pulmonary function changes according to the resected lobe. Methods: This prospective study included 59 patients requiring single lobectomy. Total volume and low-attenuation volume (LAV) for each lobe and the entire lungs were calculated based on helical computed tomography images. Vital capacity (VC), forced expiratory volume in one second (FEV1), percent FEV1 (%FEV1), percent lung diffusion capacity for carbon monoxide (%DLco), %DLco divided by the alveolar volume (%DLco/VA), modified Medical Research Council (mMRC) grades, and COPD Assessment Test (CAT) scores were compared at 3, 6, and 12 months after surgery. Results: VC was higher at 12 months than at 3 months after right upper lobectomy (RUL) or right lower lobectomy (RLL). FEV1 and %FEV1 were higher at 12 months than at 6 months after left lower lobectomy (LLL). %DLco was higher at 12 months than at 3 months after RUL or left upper lobectomy (LUL). DLco/VA, mMRC grades, and CAT scores did not change significantly in the period from 3 to 12 months after any lobectomy procedure. Compared to the predicted postoperative values, the observed values of VC for RUL, RLL, and LUL; FEV1 for RLL; %FEV1 for RLL and LUL; %DLco for LUL; and %DLco/VA for all lobectomy procedures were higher at 12 months. Conclusions: Improvements in pulmonary function and symptoms varied according to the resected lobe. Some of the observed pulmonary function values were higher than the predicted postoperative values. Pulmonary function changes may be related to the location, volume, and extent of emphysematous changes.
- 17 October 2018
- Published by Wiley in Experimental Physiology
- Vol. 103 (12) , 1656-1665
Genioglossus muscle activity during sniff and reverse sniff in healthy men
New Findings: What is the central question of this study? Maximal sniff nasal inspiratory and reverse sniff nasal expiratory pressures are measured as inspiratory and expiratory muscle strength, respectively. Is the genioglossus muscle activated during short maximal inspiratory and expiratory efforts through the nose? What is the main finding and its importance? Genioglossus muscle activity occurred with inspiratory muscle activity during a maximal sniff and with expiratory muscle activity during a maximal reverse sniff. These results indicate that genioglossus muscle activity is closely related to the generation of maximal sniff nasal inspiratory and reverse sniff nasal expiratory pressures. Maximal sniff nasal inspiratory pressure (SNIPmax) is widely used to assess inspiratory muscle strength. The sniff nasal inspiratory pressure (SNIP) is lower in patients with neuromuscular disease with bulbar involvement compared with those without, possibly owing to impaired upper airway muscle function. However, the degree to which the genioglossus (GG) muscle, one of the upper airway muscles, is activated during inspiratory and expiratory efforts through the nose remains unclear. Therefore, we examined GG activity during short and sharp inspiratory and expiratory efforts through the nose, i.e. sniff and reverse sniff manoeuvres. In eight normal young subjects, we inserted fine wire electrodes into the GG muscle, parasternal intercostal and scalene (inspiratory) muscles and transversus abdominis (expiratory) muscle. We assessed EMG activity of each muscle and measured SNIP and reverse sniff nasal expiratory pressure (RSNEP) during sniffs and reverse sniffs from low to high intensities in the sitting position. The highest SNIP and RSNEP were analysed as SNIPmax and maximal RSNEP (RSNEPmax), respectively. In each subject, GG EMG activity increased linearly with increasing SNIP and RSNEP. The SNIPmax and RSNEPmax were −85.1 ± 15.9 and 83.2 ± 24.2 cmH2O, respectively. Genioglossus EMG activity varied with EMG activity of the parasternal intercostal and scalene muscles during generation of SNIPmax and with EMG activity of the transversus abdominis muscle during RSNEPmax. Genioglossus EMG activity during generation of SNIPmax was higher than during RSNEPmax (62.9 ± 31.1% EMG of SNIPmax, P = 0.012). These results suggested that GG activity was closely related to the generation of both SNIPmax and RSNEPmax.
- 17 October 2018
- Published by Wiley in Experimental Physiology
- Vol. 103 (12) , 1656-1665
Genioglossus muscle activity during sniff and reverse sniff in healthy men
New Findings: What is the central question of this study? Maximal sniff nasal inspiratory and reverse sniff nasal expiratory pressures are measured as inspiratory and expiratory muscle strength, respectively. Is the genioglossus muscle activated during short maximal inspiratory and expiratory efforts through the nose? What is the main finding and its importance? Genioglossus muscle activity occurred with inspiratory muscle activity during a maximal sniff and with expiratory muscle activity during a maximal reverse sniff. These results indicate that genioglossus muscle activity is closely related to the generation of maximal sniff nasal inspiratory and reverse sniff nasal expiratory pressures. Maximal sniff nasal inspiratory pressure (SNIPmax) is widely used to assess inspiratory muscle strength. The sniff nasal inspiratory pressure (SNIP) is lower in patients with neuromuscular disease with bulbar involvement compared with those without, possibly owing to impaired upper airway muscle function. However, the degree to which the genioglossus (GG) muscle, one of the upper airway muscles, is activated during inspiratory and expiratory efforts through the nose remains unclear. Therefore, we examined GG activity during short and sharp inspiratory and expiratory efforts through the nose, i.e. sniff and reverse sniff manoeuvres. In eight normal young subjects, we inserted fine wire electrodes into the GG muscle, parasternal intercostal and scalene (inspiratory) muscles and transversus abdominis (expiratory) muscle. We assessed EMG activity of each muscle and measured SNIP and reverse sniff nasal expiratory pressure (RSNEP) during sniffs and reverse sniffs from low to high intensities in the sitting position. The highest SNIP and RSNEP were analysed as SNIPmax and maximal RSNEP (RSNEPmax), respectively. In each subject, GG EMG activity increased linearly with increasing SNIP and RSNEP. The SNIPmax and RSNEPmax were −85.1 ± 15.9 and 83.2 ± 24.2 cmH2O, respectively. Genioglossus EMG activity varied with EMG activity of the parasternal intercostal and scalene muscles during generation of SNIPmax and with EMG activity of the transversus abdominis muscle during RSNEPmax. Genioglossus EMG activity during generation of SNIPmax was higher than during RSNEPmax (62.9 ± 31.1% EMG of SNIPmax, P = 0.012). These results suggested that GG activity was closely related to the generation of both SNIPmax and RSNEPmax.
- 1 February 2015
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 30, 96-101
Aminophylline increases respiratory muscle activity during hypercapnia in humans
- 1 February 2015
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 30, 96-101
Aminophylline increases respiratory muscle activity during hypercapnia in humans